Elutia (ELUT) Short term Debt (2019 - 2025)

Elutia (ELUT) posted Short term Debt of $5.0 million for Q3 2025, up 33.33% sequentially from $3.8 million in Q2 2025.

Elutia (ELUT) Short term Debt (2019 - 2025) Analysis & Trends

Elutia has reported Short term Debt for 7 years, with the latest figure at $5.0 million in Q3 2025.

Quarterly Short term Debt changed N/A year-over-year to $5.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.0 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 million, down 62.36% from the prior year.
Short term Debt improved to $5.0 million in Q3 2025 per ELUT's latest filing, from $3.8 million in the prior quarter.
Over five years, Short term Debt peaked at $8.1 million in Q3 2021 and troughed at $1.2 million in Q4 2024.
A 5-year average of $4.4 million and a median of $3.4 million in 2021 frame the typical range for Short term Debt.
The sharpest annual moves came in 2021 and 2024: Short term Debt surged 178.86% in 2021, then sank 62.36% in 2024.
Over 5 years, Short term Debt stood at $4.8 million in 2021, then surged by 69.2% to $8.1 million in 2022, then tumbled by 58.79% to $3.3 million in 2023, then sank by 62.36% to $1.2 million in 2024, then jumped by 300.0% to $5.0 million in 2025.
According to Business Quant data, Short term Debt over the past three periods registered $5.0 million, $3.8 million, and $2.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.69 Bn	197.09 Bn	7.27 Bn
2	Stryker	126.34 Bn	122.87 Bn	4.50 Bn
3	Medtronic	119.44 Bn	110.22 Bn	6.41 Bn
4	Boston Scientific	74.10 Bn	73.56 Bn	3.85 Bn
5	Edwards Lifesciences	51.73 Bn	47.48 Bn	1.35 Bn
6	Dexcom	35.11 Bn	33.16 Bn	830.00 Mn
7	GE HealthCare Technologies	33.78 Bn	31.67 Bn	2.18 Bn
8	Koninklijke Philips	26.20 Bn	22.88 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Elutia	40.75 Mn	20.85 Mn	1.45 Mn

Download Data